Eficacia broncodilatadora de la asociación de salmeterol y tiotropio en pacientes con EPOC
Authors:
- A. Baloira VillarAVA. Baloira Villar
- C. Vilariño PomboCPC. Vilariño Pombo
- 1 March 2005
- journal article
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 41 (3) , 130-134
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease?American Journal of Respiratory and Critical Care Medicine, 1999
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Quality of Life Changes in COPD Patients Treated With SalmeterolAmerican Journal of Respiratory and Critical Care Medicine, 1997
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992